Pemafibrate for high cholesterol not controlled by statins
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether pemafibrate, a new medication, can lower cholesterol better when added to statin treatment in patients whose cholesterol remains high despite taking statins regularly. The goal is to see if this combination reduces heart disease risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have high cholesterol (hypercholesterolemia)
- You have been taking a statin at a steady dose for at least 4 weeks before screening
- Your fasting triglycerides (blood fat) are below 150 mg/dL on two separate screening tests
- Your LDL-C (bad cholesterol) level meets certain thresholds based on your risk category, confirmed on two screening tests
- You have not had a heart attack, stroke, or major heart surgery in the past 3 months
- You do not have uncontrolled diabetes, thyroid disease, severe liver disease, gallstones, or severe kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a triple combination of medications (bempedoic acid, ezetimibe, and a high-intensity statin) in people who have never had a heart attack or stroke but have moderate to severe coronary artery disease. The goal is to see if this combination lowers cholesterol and reduces future heart risks more effectively than standard care.
This trial tests whether a medication called pemafibrate can help prevent future strokes in people who have had a recent stroke or TIA (mini-stroke) caused by a narrowed artery inside the brain. The medication works by lowering triglycerides (a type of fat in the blood).
This study tests a new medicine called bempedoic acid that helps lower LDL (bad) cholesterol in people who are already on statins or other cholesterol treatments. It may offer an additional option for people who need to lower their cholesterol further because of heart disease risks.
This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.
This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.
This study tests fenofibrate, a medicine that may help lower liver enzymes in people with primary biliary cholangitis (PBC). It looks at how well the drug works in everyday medical practice.
Hear when a new Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.